JPM Thematics - Genetic Therapies C2 Fonds
85,22
EUR
-0,93
EUR
-1,08
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Ionis Pharmaceuticals Inc | US4622221004 | 3,34% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,30% |
| Novartis AG Registered Shares | CH0012005267 | 3,25% |
| PTC Therapeutics Inc | US69366J2006 | 3,12% |
| Gilead Sciences Inc | US3755581036 | 3,08% |
| CRISPR Therapeutics AG | CH0334081137 | 2,84% |
| Amgen Inc | US0311621009 | 2,83% |
| Astellas Pharma Inc | JP3942400007 | 2,81% |
| Wuxi AppTec Co Ltd | CNE100003F19 | 2,76% |
| Lonza Group Ltd | CH0013841017 | 2,65% |
| Sonstige | 70,01% |